Global Heart Failure Disease Market Analysis, 2020

Name: Global Heart Failure Disease Market Analysis, 2020
Creator: MarkNtel Advisors
License: https://www.marknteladvisors.com/privacy-policy

Drug (Beta Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers, Diuretics, Inotropic Agents, Aldosterone Antagonist, Calcium Channel Blockers, O...thers (Milrinone and Flosequinan, etc.)) Surgery, Medical Devices (Ventricular Assist Device (VAD), Pacemaker, Implantable Cardioverter-Defibrillators (ICD), Continuous Positive Air Pressure Device (CPAP), Bi-Level Positive Air Pressure Device (BiPAP), Heart Pumps, By Diagnostic Test (Blood Test, Electrocardiogram (ECG), Echocardiogram, Chest X-ray, CT Scan & MRI, Others (Myocardial Biopsy, stress test, etc.) By Age Group (Upto 30 years, 31 - 64 years, 65 Years & Above), By Gender (Male, Female), By Region (North America (US, Canada, Mexico) South America (Argentina, Brazil) Europe (UK, Germany, France, Italy, Netherland, Spain, Rest of Europe) Asia-Pacific (China, Australia, Japan, India, South-East Asia, South Korea) Middle East and Africa (UAE, Saudi Arabia, South Africa) Read more

Healthcare
Jun 2020
Pages 211
Report Format: PDF, Excel, PPT

Get Actionable Insights for Smarter Decisions: Regional and country reports in one place pick a location for insights and Trends.

The Global Heart Failure Disease Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Heart Failure Disease market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

According to MarkNtel Advisors’ research report titled “Global Heart Failure Disease Market Analysis, 2020”, the Global Heart Failure Disease market is anticipated to grow at a CAGR of around 12.5% during 2020-25 on account of various factors which affect the heart, such as lack of balanced diet, lack of exercise, modifications in lifestyles, increasing work stress, unhealthy weight fluctuations, and rising smoking and alcohol consumption among people.

Moreover, cardiovascular diseases (CVD) are a major cause that lead to heart failure. Therefore, an increase in the occurrence of cardiovascular diseases across regions is projected to drive the revenue growth of Heart Failure Disease market globally.

North America Dominated the Overall Market
North America captured a considerable market share in the global Heart Failure Disease market in 2020 owing to the high costs related to the treatment of the disease in the country. The total cost of care for heart failures for the US population surged from USD 30.7 billion in 2012 to USD 43.6 billion in 2020 and it is anticipated to increase up to USD 69.7 billion by 2030.

According to the American Heart Association, the number of people diagnosed with heart failure is projected to increase by 46% by 2030, resulting in more than 8 million people with heart failure.
Along with this, the number of CVDs in Americans is expected to increase to 131.2 million by 2035 which is 45% of the total U.S. population. It can be safely assumed that heart-related diseases are the leading cause of death in the United States. Hence, this would strongly attribute toward the growth of Heart Failure Disease market in the near future as stated in the MarkNtel Advisors’ research report “Global Heart Failure Disease Market Analysis, 2020”.

According to MarkNtel Advisors’, the key players with a considerable market share Global Heart Failure Disease market include AstraZeneca, Bayer, Bristol-Myers Squibb, Cytokinetics, Amgen, Merck, Novartis, Renova Therapeutics, Servier, Stealth BioTherapeutics, Pfizer etc. To have a strong foothold in the market, the companies are launching products in the market to gain a competitive edge over other market players.

Key Questions Answered in the Market Research Report

What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of Global Heart Failure Disease Market?
What is the region wise industry size, growth drivers and challenges key market trends?
What are the key innovations, technology upgrades, opportunities, regulations in the Global Heart Failure Disease Market?
Who are the key competitors or market players and how they perform in Global Heart Failure Disease Market based on competitive benchmarking matrix?
What are the key results derived from the market surveys conducted during the course of Global Heart Failure Disease Market study?

Market Outlook, Segmentation and Statistics

Global Heart Failure Disease Market Overview
Global Heart Failure Disease Startups Ecosystem
Impact of COVID-19
Market Size & Analysis
- By Revenues (USD Million)
Market Share & Analysis
- By Treatment Types
  - Drug
    - Beta Blockers
    - Angiotensin-Converting Enzyme (ACE) Inhibitors
    - Angiotensin Receptor Blockers
    - Diuretics
    - Inotropic Agents
    - Aldosterone Antagonist
    - Calcium Channel Blockers
    - Others (Milrinone and Flosequinan, etc.)
  - Surgery
  - Medical Devices
    - Ventricular Assist Device (VAD)
    - Pacemaker
    - Implantable Cardioverter-Defibrillators (ICD)
    - Continuous Positive Air Pressure Device (CPAP)
    - Bi-Level Positive Air Pressure Device (BiPAP)
    - Heart Pumps
- By Diagnostic Test
  - Blood Test
  - Electrocardiogram (ECG)
  - Echocardiogram
  - Chest X-ray
  - CT Scan & MRI
  - Others (Myocardial Biopsy, stress test, etc.)
- By Age Group
  - Upto 30 years
  - 31 - 64 years
  - 65 Years & Above
- By Gender
  - Male
  - Female
- Region
  - North America Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - The US Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - Canada Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - Mexico Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
  - South America Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - Brazil Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - Argentina Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
  - Europe Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - The UK Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - Germany Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - France Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - Italy Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - Spain Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - The Netherlands Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
  - Middle East & Africa Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - UAE Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - Saudi Arabia Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - South Africa Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
  - Asia-Pacific Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - China Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - Japan Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - India Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - South-East Asia Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - Australia Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
    - South Korea Heart Failure Disease Market Outlook, 2015-2025F (USD Million)
Global Heart Failure Disease Market Policies, Regulations, Product Standard
Global Heart Failure Disease Market Hotspots & Opportunities
- By Company
  - Revenue Shares
  - Strategic Factorial Indexing
  - Competitor Placement in MarkNtel Quadrant
Competition Outlook
- Competitor Wise Growth Strategies
- Company Profiles

Frequently Asked Questions

Q. What is the historical year, base year and forecast year considered in the research report on Global Heart Failure Disease Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.

Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Million.

Q. What would be the growth rate or CAGR of Global Heart Failure Disease Market during 2020-25?
A. The growth rate of Global Heart Failure Disease Market during 2020-25 is forecast to be around 12.5%.

Q. Who are the key competitors or players operating in Global Heart Failure Disease Market?
A. AstraZeneca, Bayer, Bristol-Myers Squibb, Cytokinetics, Amgen, Merck, Novartis, Renova Therapeutics, Servier, Stealth BioTherapeutics, Pfizer etc., are few of the leading players in the Global Heart Failure Disease Market.

Q. Which age group segment would emerge as an opportunity area for players in Global Heart Failure Disease Market?
A. Above 65-year segment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.

Q. Which region would emerge as an opportunity area for players in Global Heart Failure Disease Market?
A. The North America grabbed a significant market share continue to grow at a highest CAGR, presenting immense opportunities for manufacturers and suppliers of Global Heart Failure Disease Market.

Frequently Asked Questions

A. AstraZeneca, Bayer, Bristol-Myers Squibb, Cytokinetics, Amgen, Merck, Novartis, Renova Therapeutics, Servier, Stealth BioTherapeutics, Pfizer etc., are few of the leading players in the Global Heart Failure Disease Market.

Introduction
1. Product Definition
2. Research Process
3. Glossary
4. Market Segmentation
Executive Summary
Global Heart Failure Disease Market Overview
Global Heart Failure Disease Startups Ecosystem
Impact of COVID-19
Expert Verbatim- Interview Excerpts of 10 industry experts
Global Heart Failure Disease Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Treatment Types
    1. Drug
      1. Beta Blockers
      2. Angiotensin-Converting Enzyme (ACE) Inhibitors
      3. Angiotensin Receptor Blockers
      4. Diuretics
      5. Inotropic Agents
      6. Aldosterone Antagonist
      7. Calcium Channel Blockers
      8. Others (Milrinone and Flosequinan, etc.)
    2. Surgery
    3. Medical Devices
      1. Ventricular Assist Device (VAD)
      2. Pacemaker
      3. Implantable Cardioverter-Defibrillators (ICD)
      4. Continuous Positive Air Pressure Device (CPAP)
      5. Bi-Level Positive Air Pressure Device (BiPAP)
      6. Heart Pumps
  2. By Diagnostic Test
    1. Blood Test
    2. Electrocardiogram (ECG)
    3. Echocardiogram
    4. Chest X-ray
    5. CT Scan & MRI
    6. Others (Myocardial Biopsy, stress test, etc.)
  3. By Age Group
    1. Upto 30 years
    2. 31 - 64 years
    3. 65 Years & Above
  4. By Gender
    1. Male
    2. Female
  5. By Region
    1. North America
    2. South America
    3. Europe
    4. Asia-Pacific
    5. Middle East & Africa
  6. By Company
    1. Revenue Shares
    2. Strategic Factorial Indexing
    3. Competitor Placement in MarkNtel Quadrant
  7. Market Attractiveness Index
    1. By Treatment Types
    2. By Diagnostic Test
    3. By Age Group
    4. By Gender
    5. By Region
North America Heart Failure Disease Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Treatment Types
  2. By Diagnostic Test
  3. By Age Group
  4. By Gender
  5. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
4. Canada Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
5. Mexico Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
6. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
South America Heart Failure Disease Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Treatment Types
  2. By Diagnostic Test
  3. By Age Group
  4. By Gender
  5. By Country
    1. Brazil
    2. Argentina
    3. Others
3. Brazil Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
4. Argentina Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
5. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
Europe Heart Failure Disease Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Treatment Types
  2. By Diagnostic Test
  3. By Age Group
  4. By Gender
  5. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Netherland
    7. Others
3. The UK Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
4. Germany Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
5. France Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
6. Italy Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
7. Spain Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
8. Netherland Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
9. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
Asia-Pacific Heart Failure Disease Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Treatment Types
  2. By Diagnostic Test
  3. By Age Group
  4. By Gender
  5. By Country
    1. China
    2. India
    3. Japan
    4. Australia
    5. South Korea
    6. South East Asia
    7. Others
3. China Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
4. India Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
5. Japan Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
6. Australia Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
7. South Korea Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
8. South East Asia Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
9. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
Middle East & Africa Heart Failure Disease Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Treatment Types
  2. By Diagnostic Test
  3. By Age Group
  4. By Gender
  5. By Country
    1. UAE
    2. Saudi Arabia
    3. South Africa
    4. Others
3. UAE Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
4. Saudi Arabia Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
5. South Africa Heart Failure Disease Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Treatment Types
6. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
Global Heart Failure Disease Market Dynamics
1. Drivers
2. Challenges
3. Impact Analysis
Global Heart Failure Disease Market Regulations, Product Standards
Global Heart Failure Disease Market Value Chain Analysis
Global Heart Failure Disease Market Hotspots & Opportunities
Global Heart Failure Disease Market Trends & Developments
Global Heart Failure Disease Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Competitor Wise Growth Strategies
  1. Product Portfolio
  2. Target Markets
  3. Target End Users
  4. Research & Development
  5. Strategic Alliances & Initiatives
2. Company Profiles of top companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. AstraZeneca
  2. Bayer
  3. Bristol-Myers Squibb
  4. Cytokinetics
  5. Amgen
  6. Merck
  7. Novartis
  8. Renova Therapeutics
  9. Servier
  10. Stealth BioTherapeutics
  11. Pfizer
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying